Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Longeveron Inc. (LGVN)
USD0.64
+0.01 (+2.09%)
US NASDAQ Healthcare Biotechnology
Address
1951 NW 7th Avenue 33136
Miami, FL, US
Miami, FL, US
CEO
Stephen H. Willard
Website
longeveron.com
IPO
2021-02-12
CIK 1721484 ISIN US54303L2034
Description
Longeveron Inc. is a biotechnology company currently in the clinical development stage, dedicated to pioneering cell-based therapies. These treatments are designed to address both age-related conditions and various critical, life-threatening illnesses. The company's primary investigational product is LOMECEL-B, a sophisticated cellular therapy. This product is created from medicinal signaling cells that are cultivated and expanded after being harvested from the bone marrow of healthy young adult donors. Longeveron is actively conducting Phase 1 and Phase 2 clinical trials to evaluate LOMECEL-B's potential across a diverse range of indications. These include age-related frailty, Alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome (ARDS), and hypoplastic left heart syndrome (HLHS). Established in 2014, Longeveron Inc. operates from its headquarters in Miami, Florida.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.64
+0.01 (+2.09%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
462.8K
Beta
-0.38
Float Shares
19.82M
Free Float %
85.0%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -10.48% | -16.49% | -35.34% | +40.42% | +6.02% | +48.24% | -48.97% | -97.73% | -98.58% | -98.99% | -98.99% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (4 ratings, all time)
Buy
Price Targets & DCF
Current price
0.64
Low
10.00
+1,474.1%
Consensus
10.00
+1,474.1%
Median
10.00
+1,474.1%
High
10.00
+1,474.1%
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 2 | +1 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | — | — |
| All Time | 1 |
10.00
+1,474.1%
|
Quality scores
Altman Z-Score
-22.60
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
1 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-49.9% Q1'26: +4.5% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%-20.6% Q1'26: +44.1% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-1,772.0% Q1'26: -1,098.0% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-1,942.2% Q1'26: +0.0% (vs Q1'25)
-
ROIC Biotechnology: -16.1%-1,267.0% Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+18.0% Q1'26: +65.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.04× Q1'26: -0.04× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 2 EPS Ana. |
Dec 2027 3 Rev. Ana. 3 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.31M
est: 1.30M (+0.5%)
|
1.22M
est: 1.15M (+6.2%)
|
709.0K
est: 1.23M (-42.3%)
|
2.39M
est: 2.16M (+10.8%)
|
1.20M
est: 919.7K (+30.4%)
|
989.8K
290.2K – 1.78M
+7.6% YoY
|
6.02M
1.77M – 12.67M
+508.2% YoY
|
40.43M
12.35M – 69.85M
+571.7% YoY
|
216.31M
66.07M – 373.70M
+435.0% YoY
|
308.61M
94.27M – 533.16M
+42.7% YoY
|
| EBITDA |
-16.13M
est: -1.18M (-1,272.2%)
|
-17.15M
est: -1.04M (-1,548.8%)
|
-20.08M
est: -1.23M (-1,534.1%)
|
-15.56M
est: -2.16M (-621.2%)
|
-22.06M
est: -919.7K (-2,298.7%)
|
-989.8K
-1.78M – -290.2K
-7.6% YoY
|
-6.02M
-12.67M – -1.77M
-508.2% YoY
|
-40.43M
-69.85M – -12.35M
-571.7% YoY
|
-216.31M
-373.70M – -66.07M
-435.0% YoY
|
-308.61M
-533.16M – -94.27M
-42.7% YoY
|
| EBIT |
-17.04M
est: -1.21M (-1,306.5%)
|
-18.04M
est: -1.07M (-1,582.8%)
|
-21.03M
est: -1.23M (-1,611.1%)
|
-16.52M
est: -2.16M (-665.6%)
|
-23.29M
est: -919.7K (-2,432.1%)
|
-989.8K
-1.78M – -290.2K
-7.6% YoY
|
-6.02M
-12.67M – -1.77M
-508.2% YoY
|
-40.43M
-69.85M – -12.35M
-571.7% YoY
|
-216.31M
-373.70M – -66.07M
-435.0% YoY
|
-308.61M
-533.16M – -94.27M
-42.7% YoY
|
| Net Income |
-17.05M
est: -140.71M (+87.9%)
|
-18.84M
est: -19.98M (+5.7%)
|
-21.41M
est: -27.90M (+23.3%)
|
-15.97M
est: -61.02M (+73.8%)
|
-22.70M
est: -22.70M (+0.0%)
|
-10.57M
-14.53M – -6.60M
+53.5% YoY
|
-10.21M
-16.03M – -4.40M
+3.3% YoY
|
-5.21M
-9.92M – -494.9K
+49.0% YoY
|
30.41M
2.95M – 59.17M
+684.0% YoY
|
46.40M
4.51M – 90.29M
+52.6% YoY
|
| SGA |
10.95M
est: 9.85M (+11.2%)
|
9.17M
est: 8.72M (+5.2%)
|
12.18M
est: 11.66M (+4.5%)
|
10.27M
est: 20.47M (-49.8%)
|
12.05M
est: 8.72M (+38.1%)
|
9.39M
2.75M – 16.87M
+7.6% YoY
|
57.08M
16.82M – 120.18M
+508.2% YoY
|
383.45M
117.13M – 662.45M
+571.7% YoY
|
2.05B
626.63M – 3.54B
+435.0% YoY
|
2.93B
894.02M – 5.06B
+42.7% YoY
|
| EPS |
-9.00
est: -9.45 (+4.8%)
|
-9.00
est: -8.70 (-3.4%)
|
-10.22
est: -8.27 (-23.6%)
|
-1.07
est: -3.69 (+71.0%)
|
-1.29
est: -1.43 (+9.6%)
|
-0.66
-0.83 – -0.38
+53.9% YoY
|
-0.51
-0.91 – -0.25
+22.8% YoY
|
-0.29
-0.56 – -0.03
+42.9% YoY
|
1.73
0.17 – 3.37
+696.6% YoY
|
2.64
0.26 – 5.14
+52.6% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-11 | Maxim Group | Buy | Hold | Downgrade |
| 2026-05-04 | HC Wainwright & Co. | Buy | Buy | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-01 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-21.12M
OE per share TTM
-1.20
Owner's Yield
-122.78%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
171.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
5
Total invested
80.2K
Insider transactions (90d)
5
Beneficial owners (>5%)
8
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Joshua M. Hare, M.D. | 7.93M | 42.40% | 7.93M | — | 7.93M | — | IN | Florida | 2021-02-17 | ↗ |
| 2 | Donald M. Soffer | 7.87M | 42.10% | 100.0K | 7.77M | 100.0K | 7.77M | IN | — | 2021-02-26 | ↗ |
| 3 | DS MED LLC | 7.77M | 41.60% | — | 7.77M | — | 7.77M | PN | — | 2021-02-26 | ↗ |
| 4 | Armistice Capital, LLC | 1.84M | 7.31% | — | 1.84M | — | — | IA, OO | Delaware | 2024-02-14 | ↗ |
| 5 | Steven Boyd | 1.84M | 7.31% | — | 1.84M | — | — | HC, IN | Delaware | 2024-02-14 | ↗ |
| 6 | Daniel B. Asher | 676.2K | 4.99% | — | 676.2K | — | 676.2K | HC, IN | United States of America | 2024-07-26 | ↗ |
| 7 | Intracoastal Capital LLC | 676.2K | 4.99% | — | 676.2K | — | 676.2K | OO | United States of America | 2024-07-26 | ↗ |
| 8 | Mitchell P. Kopin | 676.2K | 4.99% | — | 676.2K | — | 676.2K | HC, IN | United States of America | 2024-07-26 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
5
-24 vs prev Q
New positions
1
Closed positions
25
Increased
1
Reduced
1
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 499.1K -6.4K (-1.3%) | 252.6K -126.6K (-33.4%) | 2.72% -0.651 pp | 0.00% +0.000 pp | USD1.05 -51.4% | 8 qtrs — |
| 2 | GEODE CAPITAL MANAGEMENT, LLC | 141.5K +— (+0.0%) | 71.6K -34.5K (-32.5%) | 0.77% -0.172 pp | 0.00% +0.000 pp | USD1.83 -72.1% | 7 qtrs — |
| 3 | UBS GROUP AG | 60.2K -3.8K (-5.9%) | 30.5K -17.5K (-36.5%) | 0.33% -0.099 pp | 0.00% +0.000 pp | USD1.47 -65.3% | 8 qtrs — |
| 4 | NORTHERN TRUST CORP | 48.4K +32.5K (+204.7%) | 24.5K +12.6K (+105.6%) | 0.26% +0.158 pp | 0.00% +0.000 pp | USD0.91 -44.0% | 5 qtrs — |
| 5 | STATE STREET CORP | 45.4K +— (+0.0%) | 23.0K -11.1K (-32.5%) | 0.25% -0.055 pp | 0.00% +0.000 pp | USD1.80 -71.7% | 6 qtrs — |
| 6 | XTX TOPCO LTD | 31.5K +31.5K (+100.0%) | 15.9K +15.9K (+100.0%) | 0.17% +0.171 pp | 0.00% +0.000 pp | USD0.51 +0.0% | 3 qtrs — |
| 7 | CAPITAL INVESTMENT ADVISORY SERVICES, LLC | 26.5K +— (+0.0%) | 13.4K -6.5K (-32.5%) | 0.14% -0.032 pp | 0.00% -0.001 pp | USD1.57 -67.5% | 7 qtrs — |
| 8 | COMMONWEALTH EQUITY SERVICES, LLC | 25.2K +— (+0.0%) | 12.7K -6.3K (-33.0%) | 0.14% -0.031 pp | 0.00% +0.000 pp | USD1.55 -67.1% | 5 qtrs — |
| 9 | HAMILTON POINT INVESTMENT ADVISORS, LLC | 22.4K +— (+0.0%) | 11.4K -5.5K (-32.5%) | 0.12% -0.027 pp | 0.00% -0.001 pp | USD0.75 -32.0% | 2 qtrs — |
| 10 | MONETA GROUP INVESTMENT ADVISORS LLC | 21.3K +9.3K (+77.5%) | 10.8K +1.8K (+19.7%) | 0.12% +0.036 pp | 0.00% +0.000 pp | USD0.64 -20.3% | 2 qtrs — |
| 11 | CITADEL ADVISORS LLC | 20.3K +20.3K (+100.0%) | 10.3K +10.3K (+100.0%) | 0.11% +0.110 pp | 0.00% +0.000 pp | USD0.51 +0.0% | 3 qtrs — |
| 12 | LIDO ADVISORS, LLC | 11.2K +— (+0.0%) | 8.4K +— (+0.0%) | 0.06% -0.014 pp | 0.00% +0.000 pp | USD1.30 -60.8% | 3 qtrs — |
| 13 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 14.4K +14.4K (+100.0%) | 7.3K +7.3K (+100.0%) | 0.08% +0.078 pp | 0.00% +0.000 pp | USD0.51 +0.0% | 1 qtrs NEW |
| 14 | HRT FINANCIAL LP | 12.0K -5.3K (-30.5%) | 6.0K -6.0K (-50.0%) | 0.07% -0.050 pp | 0.00% +0.000 pp | USD0.75 -32.0% | 2 qtrs — |
| 15 | TWO SIGMA SECURITIES, LLC | 10.2K -2.7K (-20.9%) | 5.1K -4.5K (-46.6%) | 0.06% -0.030 pp | 0.00% -0.001 pp | USD0.75 -32.0% | 2 qtrs — |
| 16 | BLACKROCK, INC. | 10.0K +— (+0.0%) | 5.1K -2.4K (-32.5%) | 0.05% -0.012 pp | 0.00% +0.000 pp | USD1.94 -73.7% | 6 qtrs — |
| 17 | BANK OF MONTREAL /CAN/ | 10.0K +— (+0.0%) | 5.1K -2.4K (-32.5%) | 0.05% -0.012 pp | 0.00% +0.000 pp | USD1.94 -73.7% | 6 qtrs — |
| 18 | CITIGROUP INC | 4.2K +4.2K (+100.0%) | 2.1K +2.1K (+100.0%) | 0.02% +0.023 pp | 0.00% +0.000 pp | USD0.51 +0.0% | 1 qtrs NEW |
| 19 | STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 2.4K +— (+0.0%) | 1.2K -581.0 (-32.5%) | 0.01% -0.003 pp | 0.00% +0.000 pp | USD1.55 -67.1% | 4 qtrs — |
| 20 | TOWER RESEARCH CAPITAL LLC (TRC) | 2.1K -181.0 (-7.9%) | 1.1K -652.0 (-37.8%) | 0.01% -0.004 pp | 0.00% +0.000 pp | USD1.30 -60.8% | 8 qtrs — |
| 21 | ADVISOR GROUP HOLDINGS, INC. | 2.0K +— (+0.0%) | 1.0K -520.0 (-33.8%) | 0.01% -0.002 pp | 0.00% +0.000 pp | USD1.94 -73.7% | 6 qtrs — |
| 22 | CORNERSTONE PLANNING GROUP LLC | 1.1K +— (+0.0%) | 668.00 -274.0 (-29.1%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD0.75 -32.0% | 2 qtrs — |
| 23 | MORGAN STANLEY | 689.00 +1.0 (+0.1%) | 349.00 -167.0 (-32.4%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD1.66 -69.3% | 8 qtrs — |
| 24 | FARTHER FINANCE ADVISORS, LLC | 650.00 +650.0 (+100.0%) | 329.00 +329.0 (+100.0%) | 0.00% +0.004 pp | 0.00% +0.000 pp | USD0.50 +2.0% | 1 qtrs NEW |
| 25 | JONES FINANCIAL COMPANIES LLLP | 300.00 +300.0 (+100.0%) | 152.00 +152.0 (+100.0%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD0.50 +2.0% | 1 qtrs NEW |
| 26 | BANK OF AMERICA CORP /DE/ | 146.00 +8.0 (+5.8%) | 74.00 -30.0 (-28.8%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD1.43 -64.3% | 7 qtrs — |
| 27 | ALLWORTH FINANCIAL LP | 130.00 +— (+0.0%) | 66.00 -32.0 (-32.7%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD1.30 -60.8% | 3 qtrs — |
| 28 | — | 78.00 +— (+0.0%) | 39.00 -20.0 (-33.9%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD0.74 -31.1% | 2 qtrs — |
| 29 | SBI SECURITIES CO., LTD. | 60.00 +— (+0.0%) | 30.00 -15.0 (-33.3%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD1.55 -67.1% | 5 qtrs — |
| 30 | JANE STREET GROUP, LLC | — -43.9K (-100.0%) | — -33.0K (-100.0%) | 0.00% -0.293 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 31 | VIRTU FINANCIAL LLC | — -14.4K (-100.0%) | — -11.0K (-100.0%) | 0.00% -0.096 pp | 0.00% -0.001 pp | USD— | 5 qtrs SOLD |
| 32 | RENAISSANCE TECHNOLOGIES LLC | — -56.6K (-100.0%) | — -42.5K (-100.0%) | 0.00% -0.377 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 11 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard Extended Market ETF VXF | 0.00% | 136.4K | 0.05% |
| 2 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 591.08 | 0.03% |
| 3 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 1.6K | 0.17% |
| 4 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 119.88 | 0.17% |
| 5 | Vanguard Total Stock Market ETF VTI | 0.00% | 277.4K | 0.03% |
| 6 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 608.39 | 0.22% |
| 7 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 330.94 | 0.22% |
| 8 | Vanguard Balanced ETF Portfolio VBAL.TO | 0.00% | 133.58 | 0.22% |
| 9 | Vanguard Conservative ETF Portfolio VCNS.TO | 0.00% | 14.74 | 0.22% |
| 10 | Vanguard Conservative Income ETF Portfolio VCIP.TO | 0.00% | 2.07 | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Ratio by volume
0.00
Bearish
Buys
0
Sells
5
Shares acquired
—
Shares disposed
45.3K
Cash buys
—
Cash sales
—
Net activity
-45,274
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-01 | Willard Stephen H | Officer | A-Award | A | Class A Common Stock | 500,000 | 0.00 | — | 789,727 | D | ↗ |
| 2026-05-01 | Locklear Lisa | Officer | A-Award | A | Class A Common Stock | 250,000 | 0.00 | — | 465,686 | D | ↗ |
| 2026-05-01 | Lehr Paul T | Officer | A-Award | A | Class A Common Stock | 250,000 | 0.00 | — | 588,566 | D | ↗ |
| 2026-05-01 | Blass Devin | Officer | A-Award | A | Class A Common Stock | 250,000 | 0.00 | — | 441,543 | D | ↗ |
| 2026-05-01 | Agafonova Nataliya | Officer | A-Award | A | Class A Common Stock | 250,000 | 0.00 | — | 453,419 | D | ↗ |
| 2026-04-01 | Willard Stephen H | Officer | F-InKind | D | Class A Common Stock | 4,740 | 1.12 | 5.3K | 289,727 | D | ↗ |
| 2026-04-01 | Locklear Lisa | Officer | F-InKind | D | Class A Common Stock | 13,145 | 1.12 | 14.7K | 215,686 | D | ↗ |
| 2026-04-01 | Lehr Paul T | Officer | F-InKind | D | Class A Common Stock | 5,611 | 1.12 | 6.3K | 338,566 | D | ↗ |
| 2026-04-01 | Blass Devin | Officer | F-InKind | D | Class A Common Stock | 8,633 | 1.12 | 9.7K | 191,543 | D | ↗ |
| 2026-04-01 | Agafonova Nataliya | Officer | F-InKind | D | Class A Common Stock | 13,145 | 1.12 | 14.7K | 203,419 | D | ↗ |
| 2026-03-02 | Willard Stephen H | Officer | A-Award | A | Class A Common Stock | 200,000 | 0.00 | — | 294,467 | D | ↗ |
| 2026-02-11 | Willard Stephen H | Officer | — | — | Class A Common Stock | 0 | 0.00 | — | 0 | D | ↗ |
| 2026-01-02 | Powell James Nathaniel | Officer | F-InKind | D | Class A Common Stock | 2,464 | 0.59 | 1.5K | 125,593 | D | ↗ |
| 2026-01-02 | Locklear Lisa | Officer | F-InKind | D | Class A Common Stock | 10,250 | 0.59 | 6.1K | 228,831 | D | ↗ |
| 2026-01-02 | Lehr Paul T | Officer | F-InKind | D | Class A Common Stock | 6,952 | 0.59 | 4.1K | 344,177 | D | ↗ |
| 2026-01-02 | Blass Devin | Officer | F-InKind | D | Class A Common Stock | 10,700 | 0.59 | 6.3K | 200,176 | D | ↗ |
| 2026-01-02 | Agafonova Nataliya | Officer | F-InKind | D | Class A Common Stock | 10,250 | 0.59 | 6.1K | 216,564 | D | ↗ |
| 2025-10-01 | Powell James Nathaniel | Officer | F-InKind | D | Class A Common Stock | 2,389 | 0.74 | 1.8K | 128,057 | D | ↗ |
| 2025-10-01 | Paletta George A. Jr. | Director | A-Award | A | Class A Common Stock | 34,000 | 0.00 | — | 34,000 | D | ↗ |
| 2025-10-01 | Locklear Lisa | Officer | F-InKind | D | Class A Common Stock | 11,883 | 0.74 | 8.8K | 239,081 | D | ↗ |
| 2025-10-01 | Lehr Paul T | Officer | F-InKind | D | Class A Common Stock | 4,944 | 0.74 | 3.7K | 351,129 | D | ↗ |
| 2025-10-01 | Blass Devin | Officer | F-InKind | D | Class A Common Stock | 7,609 | 0.74 | 5.6K | 210,876 | D | ↗ |
| 2025-10-01 | Agafonova Nataliya | Officer | F-InKind | D | Class A Common Stock | 11,883 | 0.74 | 8.8K | 226,814 | D | ↗ |
| 2025-09-04 | Powell James Nathaniel | Officer | A-Award | A | Class A Common Stock | 50,000 | 0.00 | — | 130,446 | D | ↗ |
| 2025-08-11 | Powell James Nathaniel | Officer | — | — | Warrant (right to buy) | 44,115 | 0.85 | 37.5K | 0 | D | ↗ |
| 2025-08-11 | Locklear Lisa | Officer | P-Purchase | A | Warrant (right to buy) | 29,415 | 0.85 | 25.0K | 29,415 | D | ↗ |
| 2025-08-11 | Baluch Khoso | Director | P-Purchase | A | Warrant (right to buy) | 29,415 | 0.85 | 25.0K | 29,415 | D | ↗ |
| 2025-07-15 | Ungaro Ursula | Director | A-Award | A | Class A Common Stock | 17,000 | 0.00 | — | 41,000 | D | ↗ |
| 2025-07-15 | Soffer Rock | Director | A-Award | A | Class A Common Stock | 17,000 | 0.00 | — | 226,034 | D | ↗ |
| 2025-07-15 | Motwani Neha J. | Director | A-Award | A | Class A Common Stock | 17,000 | 0.00 | — | 33,000 | D | ↗ |
| 2025-07-15 | Locklear Lisa | Officer | A-Award | A | Stock Option (right to buy) | 34,000 | 1.47 | 50.0K | 34,000 | D | ↗ |
| 2025-07-15 | Lehr Paul T | Officer | A-Award | A | Class A Common Stock | 102,000 | 0.00 | — | 356,073 | D | ↗ |
| 2025-07-15 | Kender Richard N | Director | A-Award | A | Class A Common Stock | 17,000 | 0.00 | — | 33,000 | D | ↗ |
| 2025-07-15 | Hashad Mohamed Wa'el Ahmed | Officer | A-Award | A | Stock Option (right to buy) | 60,000 | 1.47 | 88.2K | 60,000 | D | ↗ |
| 2025-07-15 | Hare Joshua | Director / Officer / 10% Owner | A-Award | A | Stock Option (right to buy) | 109,000 | 1.47 | 160.2K | 109,000 | D | ↗ |
| 2025-07-15 | Hajjar Roger Joseph | Director | A-Award | A | Class A Common Stock | 17,000 | 0.00 | — | 33,000 | D | ↗ |
| 2025-07-15 | Blass Devin | Officer | A-Award | A | Stock Option (right to buy) | 34,000 | 1.47 | 50.0K | 34,000 | D | ↗ |
| 2025-07-15 | Baluch Khoso | Director | A-Award | A | Class A Common Stock | 17,000 | 0.00 | — | 40,750 | D | ↗ |
| 2025-07-15 | Agafonova Nataliya | Officer | A-Award | A | Stock Option (right to buy) | 34,000 | 1.47 | 50.0K | 34,000 | D | ↗ |
| 2025-07-01 | Locklear Lisa | Officer | F-InKind | D | Class A Common Stock | 7,431 | 1.28 | 9.5K | 137,198 | D | ↗ |
| 2025-07-01 | Lehr Paul T | Officer | F-InKind | D | Class A Common Stock | 1,562 | 1.28 | 2.0K | 254,073 | D | ↗ |
| 2025-07-01 | Hashad Mohamed Wa'el Ahmed | Officer | F-InKind | D | Class A Common Stock | 13,146 | 1.28 | 16.8K | 240,904 | D | ↗ |
| 2025-07-01 | Hare Joshua | Director / Officer / 10% Owner | A-Award | A | Stock Option (right to buy) | 49,219 | 1.28 | 63.0K | 49,219 | D | ↗ |
| 2025-07-01 | Blass Devin | Officer | F-InKind | D | Class A Common Stock | 4,599 | 1.28 | 5.9K | 116,485 | D | ↗ |
| 2025-07-01 | Agafonova Nataliya | Officer | F-InKind | D | Class A Common Stock | 7,431 | 1.28 | 9.5K | 136,697 | D | ↗ |
| 2025-06-23 | Lehr Paul T | Officer | A-Award | A | Class A Common Stock | 163,043 | 0.00 | — | 319,793 | D | ↗ |
| 2025-06-13 | Hare Joshua | Director / Officer / 10% Owner | A-Award | A | Stock Option (right to buy) | 71,254 | 1.33 | 94.8K | 71,254 | D | ↗ |
| 2025-05-30 | Soffer Rock | Director | S-Sale | D | Class A Common Stock | 11,000 | 1.25 | 13.8K | 209,034 | D | ↗ |
| 2025-05-29 | Soffer Rock | Director | S-Sale | D | Class A Common Stock | 10,000 | 1.30 | 13.0K | 220,034 | D | ↗ |
| 2025-05-22 | Soffer Rock | Director | S-Sale | D | Class A Common Stock | 2,000 | 1.32 | 2.6K | 230,034 | D | ↗ |
| 2025-05-16 | Hare Joshua | Director / Officer / 10% Owner | S-Sale | D | Class A Common Stock | 5,250 | 1.40 | 7.4K | 721,796 | D | ↗ |
| 2025-04-16 | Blass Devin | Officer | — | — | Class A Common Stock | 0 | 0.00 | — | 121,084 | D | ↗ |
| 2025-04-01 | Locklear Lisa | Officer | F-InKind | D | Class A Common Stock | 7,566 | 1.50 | 11.3K | 144,629 | D | ↗ |
| 2025-04-01 | Lehr Paul T | Officer | F-InKind | D | Class A Common Stock | 1,599 | 1.50 | 2.4K | 156,750 | D | ↗ |
| 2025-04-01 | Hashad Mohamed Wa'el Ahmed | Officer | F-InKind | D | Class A Common Stock | 13,384 | 1.50 | 20.1K | 254,050 | D | ↗ |
| 2025-04-01 | Agafonova Nataliya | Officer | F-InKind | D | Class A Common Stock | 7,566 | 1.50 | 11.3K | 144,128 | D | ↗ |
| 2025-03-04 | Hare Joshua | Director / Officer / 10% Owner | A-Award | A | Stock Option (right to buy) | 71,254 | 1.33 | 94.8K | 71,254 | D | ↗ |
| 2025-01-02 | Locklear Lisa | Officer | F-InKind | D | Class A Common Stock | 6,120 | 1.79 | 11.0K | 152,195 | D | ↗ |
| 2025-01-02 | Lehr Paul T | Officer | F-InKind | D | Class A Common Stock | 1,205 | 1.79 | 2.2K | 158,349 | D | ↗ |
| 2025-01-02 | Hashad Mohamed Wa'el Ahmed | Officer | F-InKind | D | Class A Common Stock | 10,827 | 1.79 | 19.4K | 267,434 | D | ↗ |
| 2025-01-02 | Agafonova Nataliya | Officer | F-InKind | D | Class A Common Stock | 6,120 | 1.79 | 11.0K | 151,694 | D | ↗ |
| 2024-12-02 | Baluch Khoso | Director | S-Sale | D | Class A Common Stock | 1,250 | 2.07 | 2.6K | 23,750 | D | ↗ |
| 2024-10-01 | Locklear Lisa | Officer | F-InKind | D | Class A Common Stock | 5,316 | 1.88 | 10.0K | 158,315 | D | ↗ |
| 2024-10-01 | Lehr Paul T | Officer | F-InKind | D | Class A Common Stock | 990 | 1.88 | 1.9K | 159,554 | D | ↗ |
| 2024-10-01 | Hashad Mohamed Wa'el Ahmed | Officer | F-InKind | D | Class A Common Stock | 13,357 | 1.88 | 25.1K | 278,261 | D | ↗ |
| 2024-10-01 | Agafonova Nataliya | Officer | F-InKind | D | Class A Common Stock | 5,316 | 1.88 | 10.0K | 157,814 | D | ↗ |
| 2024-08-15 | Ungaro Ursula | Director | A-Award | A | Class A Common Stock | 23,500 | 0.00 | — | 24,000 | — | ↗ |
| 2024-08-15 | Soffer Rock | Director | A-Award | A | Class A Common Stock | 23,500 | 0.00 | — | 232,034 | — | ↗ |
| 2024-08-15 | Locklear Lisa | Officer | A-Award | A | Stock Option (Right to Buy) | 16,250 | 2.46 | 40.0K | 16,250 | — | ↗ |
| 2024-08-15 | Lehr Paul T | Officer | A-Award | A | Class A Common Stock | 178,133 | 0.00 | — | 320,214 | — | ↗ |
| 2024-08-15 | Hashad Mohamed Wa'el Ahmed | Officer | A-Award | A | Stock Option (right to buy) | 28,750 | 2.46 | 70.7K | 28,750 | — | ↗ |
| 2024-08-15 | Hare Neil E | Director | A-Award | A | Class A Common Stock | 23,500 | 0.00 | — | 29,352 | — | ↗ |
| 2024-08-15 | Hare Joshua | Director / Officer / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 6,500 | 2.46 | 16.0K | 6,500 | — | ↗ |
| 2024-08-15 | Baluch Khoso | Director | A-Award | A | Class A Common Stock | 23,500 | 0.00 | — | 38,375 | — | ↗ |
| 2024-08-15 | Agafonova Nataliya | Officer | A-Award | A | Stock Option (right to buy) | 16,250 | 2.46 | 40.0K | 16,250 | — | ↗ |
| 2024-07-02 | Motwani Neha J. | Director | — | D | Class A Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-07-02 | Hajjar Roger Joseph | Director | — | D | Class A Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-07-01 | Locklear Lisa | Officer | F-InKind | D | Class A Common Stock | 357 | 1.57 | 560.49 | 2,916 | — | ↗ |
| 2024-06-09 | Baluch Khoso | Director | F-InKind | D | Common Stock | 125 | 1.06 | 132.50 | 14,875 | — | ↗ |
| 2024-06-03 | Lehr Paul T | Officer | F-InKind | D | Class A Common Stock | 325 | 1.04 | 338.00 | 142,081 | — | ↗ |
| 2024-05-10 | Kender Richard N | Director | A-Award | A | Class A Common Stock | 16,000 | 1.46 | 23.3K | 16,000 | — | ↗ |
| 2024-05-02 | Locklear Lisa | Officer | F-InKind | D | Class A Common Stock | 410 | 2.83 | 1.2K | 3,273 | — | ↗ |
| 2024-05-02 | Agafonova Nataliya | Officer | F-InKind | D | Class A Common Stock | 308 | 2.83 | 871.64 | 1,771 | — | ↗ |
| 2024-04-11 | Soffer Rock | Director | P-Purchase | A | Warrant (right to buy) | 31,915 | 2.35 | 75.0K | 31,915 | — | ↗ |
| 2024-04-11 | Hashad Mohamed Wa'el Ahmed | Director / Officer | P-Purchase | A | Warrant (right to buy) | 10,638 | 2.35 | 25.0K | 10,638 | — | ↗ |
| 2024-04-11 | Hare Joshua | Director / Officer / 10% Owner | P-Purchase | A | Warrant (right to buy) | 42,553 | 2.35 | 100.0K | 42,553 | — | ↗ |
| 2024-04-10 | Soffer Rock | Director | P-Purchase | A | Class A Common Stock | 106,383 | 2.35 | 250.0K | 176,619 | — | ↗ |
| 2024-04-10 | Hare Joshua | Director / Officer / 10% Owner | P-Purchase | A | Warrant (right to buy) | 106,383 | 2.35 | 250.0K | 106,383 | — | ↗ |
| 2024-03-12 | Hashad Mohamed Wa'el Ahmed | Director / Officer | A-Award | A | Common Stock, par value $0.001 per share | 80,200 | 0.00 | — | 122,643 | — | ↗ |
| 2024-01-10 | Ross Cathy | Director | P-Purchase | A | Common Stock | 5,000 | 1.31 | 6.5K | 10,000 | — | ↗ |
| 2024-01-02 | Locklear Lisa | Officer | F-InKind | D | Common Stock | 4,098 | 1.32 | 5.4K | 36,824 | — | ↗ |
| 2024-01-02 | Lehr Paul T | Officer | F-InKind | D | Common Stock | 992 | 1.32 | 1.3K | 142,406 | — | ↗ |
| 2024-01-02 | Hashad Mohamed Wa'el Ahmed | Director / Officer | F-InKind | D | Common Stock | 5,123 | 1.32 | 6.8K | 42,443 | — | ↗ |
| 2024-01-02 | Agafonova Nataliya | Officer | F-InKind | D | Common Stock | 3,074 | 1.32 | 4.1K | 20,786 | — | ↗ |
| 2023-12-29 | Baluch Khoso | Director | P-Purchase | A | Common Stock | 8,322 | 1.43 | 11.9K | 15,000 | — | ↗ |
| 2023-12-28 | PFEFFER JEFFREY | Director | P-Purchase | A | Common Stock | 10,000 | 1.35 | 13.5K | 15,000 | — | ↗ |
| 2023-12-28 | Baluch Khoso | Director | P-Purchase | A | Common Stock | 1,678 | 1.40 | 2.3K | 6,678 | — | ↗ |
| 2023-12-21 | Ungaro Ursula | Director | A-Award | A | Stock Option (Right to buy) | 12,000 | 1.25 | 15.0K | 12,000 | — | ↗ |
| 2023-12-21 | Soffer Rock | Director | A-Award | A | Stock Option (Right to buy) | 12,000 | 1.25 | 15.0K | 12,000 | — | ↗ |
| 2023-12-21 | Ross Cathy | Director | A-Award | A | Stock Option (Right to buy) | 12,000 | 1.25 | 15.0K | 12,000 | — | ↗ |
| 2023-12-21 | PFEFFER JEFFREY | Director | A-Award | A | Stock Option (Right to buy) | 12,000 | 1.25 | 15.0K | 12,000 | — | ↗ |
| 2023-12-21 | LOSORDO DOUGLAS W | Director | A-Award | A | Stock Option (Right to buy) | 12,000 | 1.25 | 15.0K | 12,000 | — | ↗ |
| 2023-12-21 | Hare Neil E | Director | A-Award | A | Stock Option (Right to buy) | 12,000 | 1.25 | 15.0K | 12,000 | — | ↗ |
| 2023-12-21 | Hare Joshua | Director / Officer / 10% Owner | A-Award | A | Stock Option (Right to buy) | 12,000 | 1.25 | 15.0K | 12,000 | — | ↗ |
| 2023-12-21 | Baluch Khoso | Director | A-Award | A | Stock Option (Right to buy) | 12,000 | 1.25 | 15.0K | 12,000 | — | ↗ |
| 2023-10-02 | Locklear Lisa | Officer | F-InKind | D | Common Stock | 4,078 | 2.29 | 9.3K | 40,922 | — | ↗ |
| 2023-10-02 | Lehr Paul T | Officer | F-InKind | D | Common Stock | 815 | 2.29 | 1.9K | 143,398 | — | ↗ |
| 2023-10-02 | Agafonova Nataliya | Officer | F-InKind | D | Common Stock | 3,059 | 2.29 | 7.0K | 23,860 | — | ↗ |
| 2023-09-21 | Hare Joshua | Director / Officer / 10% Owner | M-Exempt | A | Common Stock | 5,000 | 3.00 | 15.0K | 7,828,263 | — | ↗ |
| 2023-09-20 | Lehr Paul T | Officer | M-Exempt | D | Subscription Rights (right to buy) | 2,000 | 3.00 | 6.0K | 729,625 | — | ↗ |
| 2023-09-12 | Locklear Lisa | Officer | O-OutOfTheMoney | D | Subscription Rights (right to buy) | 5,000 | 3.00 | 15.0K | 0 | — | ↗ |
| 2023-09-12 | Hashad Mohamed Wa'el Ahmed | Officer | S-Sale | D | Subscription Rights (right to buy) | 100 | 3.00 | 300.00 | 95,805 | — | ↗ |
| 2023-09-12 | Hare Joshua | Director / Officer / 10% Owner | M-Exempt | A | Common Stock | 30,000 | 3.00 | 90.0K | 7,823,263 | — | ↗ |
| 2023-09-08 | Soffer Rock | Director | M-Exempt | A | Common Stock | 30,000 | 3.00 | 90.0K | 702,351 | — | ↗ |
| 2023-09-08 | Hare Joshua | Director / Officer / 10% Owner | S-Sale | D | Subscription Rights (right to buy) | 50,000 | 3.00 | 150.0K | 39,226,771 | — | ↗ |
| 2023-09-07 | Hare Joshua | Director / Officer / 10% Owner | S-Sale | D | Subscription Rights (right to buy) | 15,400 | 3.00 | 46.2K | 39,276,771 | — | ↗ |
| 2023-09-06 | Hare Joshua | Director / Officer / 10% Owner | S-Sale | D | Subscription Rights (right to buy) | 17,700 | 3.00 | 53.1K | 39,292,171 | — | ↗ |
| 2023-09-01 | Hashad Mohamed Wa'el Ahmed | Officer | F-InKind | D | Common Stock | 4,323 | 2.64 | 11.4K | 37,566 | — | ↗ |
| 2023-09-01 | Hare Joshua | Director / Officer / 10% Owner | S-Sale | D | Subscription Rights (right to buy) | 196,510 | 3.00 | 589.5K | 39,309,871 | — | ↗ |
| 2023-08-31 | Hare Joshua | Director / Officer / 10% Owner | S-Sale | D | Subscription Rights (right to buy) | 24,924 | 3.00 | 74.8K | 39,506,381 | — | ↗ |
| 2023-08-25 | Hare Joshua | Director / Officer / 10% Owner | S-Sale | D | Subscription Rights (right to buy) | 30,000 | 3.00 | 90.0K | 39,531,305 | — | ↗ |
| 2023-08-18 | Lehr Paul T | Officer | F-InKind | D | Common Stock | 767 | 3.25 | 2.5K | 142,213 | — | ↗ |
| 2023-08-18 | Hashad Mohamed Wa'el Ahmed | Officer | F-InKind | D | Common Stock | 4,292 | 3.25 | 13.9K | 41,889 | — | ↗ |
| 2023-08-18 | Agafonova Nataliya | Officer | F-InKind | D | Common Stock | 3,081 | 3.36 | 10.4K | 26,919 | — | ↗ |
| 2023-07-31 | Locklear Lisa | Officer | A-Award | A | Common Stock | 40,000 | 0.00 | — | 40,000 | — | ↗ |
| 2023-07-24 | Agafonova Nataliya | Officer | A-Award | A | Common Stock | 30,000 | 0.00 | — | 30,000 | — | ↗ |
| 2023-07-01 | Agafonova Nataliya | Officer | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-06-29 | Clavijo James | Officer | S-Sale | D | Common Stock | 5,000 | 3.51 | 17.6K | 47,303 | — | ↗ |
| 2023-06-28 | Clavijo James | Officer | S-Sale | D | Common Stock | 10,000 | 3.43 | 34.3K | 52,303 | — | ↗ |
| 2023-06-27 | Clavijo James | Officer | S-Sale | D | Common Stock | 8,532 | 3.48 | 29.7K | 62,303 | — | ↗ |
| 2023-06-09 | PFEFFER JEFFREY | Director | A-Award | A | Common Stock | 5,000 | 0.00 | — | 5,000 | — | ↗ |
| 2023-06-09 | Baluch Khoso | Director | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-06-02 | Lehr Paul T | Officer | F-InKind | D | Common Stock | 3,247 | 3.25 | 10.6K | 142,980 | — | ↗ |
| 2023-06-02 | Clavijo James | Officer | F-InKind | D | Common Stock | 3,247 | 3.25 | 10.6K | 71,587 | — | ↗ |
| 2023-04-05 | Hashad Mohamed Wa'el Ahmed | Officer | F-InKind | D | Common Stock | 3,819 | 2.61 | 10.0K | 46,181 | — | ↗ |
| 2023-04-03 | Lehr Paul T | Officer | F-InKind | D | Common Stock | 815 | 2.61 | 2.1K | 146,227 | — | ↗ |
| 2023-04-03 | Clavijo James | Officer | F-InKind | D | Common Stock | 815 | 2.61 | 2.1K | 74,834 | — | ↗ |
| 2023-03-01 | Hashad Mohamed Wa'el Ahmed | Officer | A-Award | A | Common Stock | 50,000 | 0.00 | — | 50,000 | — | ↗ |
| 2023-01-27 | Hare Joshua | Director / Officer | S-Sale | D | Common Stock | 20,000 | 4.28 | 85.6K | 7,793,263 | — | ↗ |
| 2023-01-03 | Lehr Paul T | Director | F-InKind | D | Common Stock | 1,472 | 3.37 | 5.0K | 147,042 | — | ↗ |
| 2023-01-03 | Clavijo James | Director | F-InKind | D | Common Stock | 1,288 | 3.37 | 4.3K | 75,649 | — | ↗ |
| 2022-12-21 | Ungaro Ursula | Director | A-Award | A | Stock Option (Right to buy) | 5,000 | 0.00 | — | 5,000 | — | ↗ |
| 2022-12-21 | Soffer Rock | Director | A-Award | A | Stock Option (Right to buy) | 5,000 | 0.00 | — | 5,000 | — | ↗ |
| 2022-12-21 | Soffer Donald M | Director | A-Award | A | Stock Option (Right to buy) | 5,000 | 0.00 | — | 5,000 | — | ↗ |
| 2022-12-21 | Ross Cathy | Director | A-Award | A | Stock Option (Right to buy) | 5,000 | 0.00 | — | 5,000 | — | ↗ |
| 2022-12-21 | LOSORDO DOUGLAS W | Director | A-Award | A | Stock Option (Right to buy) | 5,000 | 0.00 | — | 5,000 | — | ↗ |
| 2022-12-21 | Hare Neil E | Director | A-Award | A | Stock Option (Right to buy) | 5,000 | 0.00 | — | 5,000 | — | ↗ |
| 2022-12-21 | Hare Joshua | Director / Officer | A-Award | A | Stock Option (Right to buy) | 5,000 | 0.00 | — | 5,000 | — | ↗ |
| 2022-12-21 | Girolamo Todd C | Director | A-Award | A | Stock Option (Right to buy) | 5,000 | 0.00 | — | 5,000 | — | ↗ |
| 2022-12-21 | Borger Erin | Director | A-Award | A | Stock Option (Right to buy) | 5,000 | 0.00 | — | 5,000 | — | ↗ |
| 2022-12-02 | Hare Joshua | Director / Officer | S-Sale | D | Common Stock | 20,000 | 3.74 | 74.8K | 7,813,263 | — | ↗ |
| 2022-11-16 | Lehr Paul T | Director | A-Award | A | Employee Stock Option (right to buy) | 22,843 | 0.00 | — | 22,843 | — | ↗ |
| 2022-11-16 | Hare Joshua | Director / Officer | A-Award | A | Common Stock | 48,140 | 0.00 | — | 7,861,403 | — | ↗ |
| 2022-10-12 | Hare Joshua | Director / Officer | S-Sale | D | Common Stock | 100,000 | 3.61 | 361.0K | 7,813,263 | — | ↗ |
| 2022-10-03 | Lehr Paul T | Director | F-InKind | D | Common Stock | 1,435 | 3.75 | 5.4K | 148,514 | — | ↗ |
| 2022-10-03 | Clavijo James | Director | F-InKind | D | Common Stock | 1,256 | 3.75 | 4.7K | 76,937 | — | ↗ |
| 2022-07-01 | Lehr Paul T | Director | F-InKind | D | Common Stock | 1,629 | 5.94 | 9.7K | 149,949 | — | ↗ |
| 2022-07-01 | Clavijo James | Director | F-InKind | D | Common Stock | 1,426 | 5.94 | 8.5K | 78,193 | — | ↗ |
| 2022-06-03 | Lehr Paul T | Director | A-Award | A | Stock Option (right to buy) | 5,000 | 0.00 | — | 5,000 | — | ↗ |
| 2022-06-03 | Clavijo James | Director | A-Award | A | Common stock | 40,000 | 0.00 | — | 116,574 | — | ↗ |
| 2022-05-20 | Soffer Rock | Director | S-Sale | D | Common stock | 7,500 | 8.06 | 60.4K | 684,351 | — | ↗ |
| 2022-05-17 | Soffer Rock | Director | J-Other | A | Common Stock | 500,182 | 0.00 | — | 691,851 | — | ↗ |
| 2022-05-17 | Soffer Donald M | Director | J-Other | A | Common Stock | 6,535,223 | 0.00 | — | 6,693,737 | — | ↗ |
| 2022-05-17 | DS MED LLC | Director | J-Other | D | Common Stock | 7,024,208 | 0.00 | — | 0 | — | ↗ |
| 2022-04-18 | Hare Joshua | Director / Officer | S-Sale | D | Common stock | 78 | 10.00 | 780.00 | 7,913,263 | — | ↗ |
| 2022-04-13 | Soffer Rock | Director | J-Other | A | Common Stock | 139,912 | 0.00 | — | 191,669 | — | ↗ |
| 2022-04-13 | Soffer Donald M | Director | J-Other | D | Common Stock | 748,694 | 0.00 | — | 7,024,208 | — | ↗ |
| 2022-04-13 | DS MED LLC | Director | J-Other | D | Common Stock | 748,694 | 0.00 | — | 7,024,208 | — | ↗ |
| 2022-04-04 | Min Kwan-Hong Christopher | Officer | — | D | Common Stock, par value $0.001 per share | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-04-04 | Lehr Paul T | Director | F-InKind | D | Common stock | 1,472 | 15.61 | 23.0K | 111,578 | — | ↗ |
| 2022-04-04 | Green Geoff | Director | F-InKind | D | Common stock | 1,840 | 15.61 | 28.7K | 133,904 | — | ↗ |
| 2022-04-04 | Clavijo James | Director | F-InKind | D | Common stock | 1,288 | 15.61 | 20.1K | 76,574 | — | ↗ |
| 2022-02-25 | Girolamo Todd C | Director | A-Award | A | Common stock | 5,000 | 0.00 | — | 5,000 | — | ↗ |
| 2022-02-15 | Girolamo Todd C | Director | — | D | Common Stock, par value $0.01 per share | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-01-05 | Lehr Paul T | Director | F-InKind | D | Common Stock | 3,316 | 12.09 | 40.1K | 113,050 | — | ↗ |
| 2022-01-03 | Green Geoff | Officer | F-InKind | D | Common Stock | 3,979 | 12.09 | 48.1K | 135,744 | — | ↗ |
| 2022-01-03 | Clavijo James | Officer | F-InKind | D | Common Stock | 1,736 | 12.09 | 21.0K | 77,862 | — | ↗ |
| 2021-10-13 | Soffer Rock | Director | P-Purchase | A | Common stock | 12,000 | 3.76 | 45.1K | 51,757 | — | ↗ |
| 2021-10-13 | Green Geoff | Officer | P-Purchase | A | Common stock | 1,000 | 3.81 | 3.8K | 139,723 | — | ↗ |
| 2021-10-12 | Soffer Rock | Director | P-Purchase | A | Common stock | 4,000 | 3.57 | 14.3K | 39,757 | — | ↗ |
| 2021-10-12 | Hare Joshua | Director / Officer | P-Purchase | A | Common stock | 2,500 | 3.69 | 9.2K | 7,933,263 | — | ↗ |
| 2021-10-11 | Soffer Rock | Director | P-Purchase | A | Common stock | 3,900 | 3.45 | 13.5K | 35,757 | — | ↗ |
| 2021-10-08 | Hare Joshua | Director / Officer / 10% Owner | P-Purchase | A | Common stock | 3,015 | 3.39 | 10.2K | 7,930,763 | — | ↗ |
| 2021-10-07 | Lehr Paul T | Officer | P-Purchase | A | Common stock | 1,750 | 3.34 | 5.8K | 116,366 | — | ↗ |
| 2021-10-07 | Hare Joshua | Director / Officer / 10% Owner | P-Purchase | A | Common stock | 1,985 | 3.38 | 6.7K | 7,927,748 | — | ↗ |
| 2021-10-07 | Clavijo James | Officer | P-Purchase | A | Common stock | 5,000 | 3.34 | 16.7K | 79,598 | — | ↗ |
| 2021-10-01 | Lehr Paul T | Officer | F-InKind | D | Common stock | 38,752 | 3.65 | 141.4K | 114,616 | — | ↗ |
| 2021-10-01 | Green Geoff | Officer | F-InKind | D | Common stock | 43,929 | 3.65 | 160.3K | 138,723 | — | ↗ |
| 2021-10-01 | Clavijo James | Officer | F-InKind | D | Common stock | 19,052 | 3.65 | 69.5K | 74,598 | — | ↗ |
| 2021-07-20 | Lehr Paul T | Officer | A-Award | A | Common Stock | 6,167 | 0.00 | — | 153,368 | — | ↗ |
| 2021-07-20 | Hare Joshua | Director / Officer / 10% Owner | A-Award | A | Common Stock | 12,335 | 0.00 | — | 7,925,763 | — | ↗ |
| 2021-07-20 | Green Geoff | Officer | A-Award | A | Stock Option (right to buy) | 75,000 | 6.08 | 456.0K | 75,000 | — | ↗ |
| 2021-07-20 | Clavijo James | Officer | A-Award | A | Stock Option (right to buy) | 50,000 | 6.08 | 304.0K | 50,000 | — | ↗ |
| 2021-06-03 | Ungaro Ursula | Director | A-Award | A | Common stock | 5,000 | 0.00 | — | 5,000 | — | ↗ |
| 2021-06-01 | Ungaro Ursula | Director | — | D | Common Stock, par value $0.01 per share | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-05-12 | Soffer Rock | Director | A-Award | A | Common Stock | 5,000 | 0.00 | — | 31,857 | — | ↗ |
| 2021-05-12 | Soffer Donald M | Director / 10% Owner | A-Award | A | Common Stock | 5,000 | 0.00 | — | 158,514 | — | ↗ |
| 2021-05-12 | Hare Neil E | Director | A-Award | A | Common Stock | 5,000 | 0.00 | — | 58,514 | — | ↗ |
| 2021-05-12 | Hare Joshua | Director / Officer / 10% Owner | A-Award | A | Common Stock | 5,000 | 0.00 | — | 7,913,428 | — | ↗ |
| 2021-02-12 | Soffer Rock | Director | P-Purchase | A | Common Stock | 100 | 8.05 | 805.00 | 26,857 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-9.3K
Shares Outstanding
23.31M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Wa’el Hashad, Chief Executive Officer | 571.0K | — | 765.7K | 70.7K | 389.6K | 51.8K | 1.85M | 45.24% | ↗ |
| 2 | 2024 | Paul Lehr, General Counsel and Corporate Secretary | 420.2K | — | 438.2K | 40.0K | 184.3K | 144.1K | 1.23M | 38.98% | ↗ |
| 3 | 2024 | Lisa Locklear, Chief Financial Officer, Treasurer | 430.9K | — | 429.9K | 40.0K | 189.0K | 33.5K | 1.12M | 41.83% | ↗ |
| 4 | 2023 | Wa’el Hashad, Chief Executive Officer | 431.5K | — | 633.5K | 161.5K | 309.2K | 40.9K | 1.58M | 50.43% | ↗ |
| 5 | 2023 | Paul Lehr, General Counsel and Corporate Secretary | 372.3K | — | — | — | 130.3K | 51.5K | 554.1K | 0.00% | ↗ |
| 6 | 2023 | James Clavijo, Former CFO, Treasurer | 146.0K | — | — | — | — | 380.0K | 525.9K | 0.00% | ↗ |
| 7 | 2023 | Lisa Locklear, Chief Financial Officer, Treasurer | 161.5K | — | 132.4K | — | 75.0K | 11.8K | 380.8K | 34.77% | ↗ |
| 8 | 2023 | K. Chris Min, former interim CEO | 104.2K | — | — | — | — | 180.5K | 284.7K | 0.00% | ↗ |
| 9 | 2022 | K. Chris Min Former interim CEO | 261.1K | — | 1.96M | 593.4K | 69.7K | 43.6K | 2.93M | 87.20% | ↗ |
| 10 | 2022 | K. Chris Min, former interim CEO | 261.1K | — | 1.96M | 593.4K | 69.7K | 43.6K | 2.93M | 87.20% | ↗ |
| 11 | 2022 | Paul Lehr, General Counsel and Corporate Secretary | 324.7K | — | 349.2K | 105.7K | 81.2K | 42.4K | 983.2K | 46.27% | ↗ |
| 12 | 2022 | James Clavijo, Former CFO, Treasurer | 319.3K | — | 349.2K | — | 72.3K | 33.8K | 774.6K | 45.08% | ↗ |
| 13 | 2022 | James Clavijo, CFO, Treasurer | 319.3K | — | 349.2K | — | 72.3K | 33.8K | 774.6K | 45.08% | ↗ |
| 14 | 2022 | Geoff Green, Former CEO | 182.2K | 109.8K | 170.0K | — | — | 23.4K | 485.3K | 35.03% | ↗ |
| 15 | 2021 | Geoff Green, Former CEO | 324.5K | 209.8K | 1.57M | 399.0K | — | 26.7K | 2.53M | 77.83% | ↗ |
| 16 | 2021 | Geoff Green, CEO | 324.5K | 209.8K | 1.57M | 399.0K | — | 26.7K | 2.53M | 77.83% | ↗ |
| 17 | 2021 | Paul Lehr, General Counsel and Corporate Secretary | 289.3K | 155.0K | 1.32M | 266.0K | — | 21.0K | 2.06M | 77.37% | ↗ |
| 18 | 2021 | Paul Lehr, International General Counsel and Corporate Secretary | 289.3K | 155.0K | 1.32M | 266.0K | — | 21.0K | 2.06M | 77.37% | ↗ |
| 19 | 2021 | James Clavijo, CFO, Treasurer | 263.0K | 189.0K | 842.9K | 266.0K | — | 29.1K | 1.59M | 69.74% | ↗ |
| 20 | 2021 | Joshua M. Hare, M.D., CSO, | 265.6K | 132.2K | 621.1K | 266.0K | — | 52.0K | 1.32M | 66.96% | ↗ |
| 21 | 2020 | Joshua M. Hare, M.D., CSO, | 270.0K | — | — | — | — | — | 270.0K | 0.00% | ↗ |
| 22 | 2020 | Geoff Green, CEO | 210.0K | — | — | — | — | 24.3K | 234.3K | 0.00% | ↗ |
| 23 | 2020 | Paul Lehr, International General Counsel and Corporate Secretary | 175.0K | — | — | — | — | 7.7K | 182.7K | 0.00% | ↗ |
| 24 | 2020 | James Clavijo, CFO, Treasurer | 155.0K | — | — | — | — | 16.8K | 171.8K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Lisa Locklear | Chief Financial Officer, Executive Vice President & Treasurer | 675.0K | female |
| Paul T. Lehr | General Counsel & Secretary | 674.9K | male |
| Joshua Michael Hare FACC | Co-Founder, Chief Science Officer & Executive Chairman | 523.0K | female |
| Jen Dumas | Vice President of Human Resources | — | female |
| Lisa McClain-Moss | Vice President of Manufacturing | — | female |
| Nataliya Agafonova | Chief Medical Officer | — | — |
| Brian Rash | Vice President of Research & Discovery | — | male |
| Stephen H. Willard | Chief Executive Officer | — | male |
| Devin Blass | Chief Technology Officer & Senior Vice President of Chemistry, Manufacturing, and Controls | — | male |
| Heather Zhou | Vice President & Corporate Controller | — | female |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for LGVN
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
